Cognitive effects of topiramate, gabapentin, and lamotrigine in healthy young adults.
about
Post-traumatic epilepsy: current and emerging treatment optionsThe effects of antiepileptic drugs on cognitive functional magnetic resonance imagingPharmaco fMRI: Determining the functional anatomy of the effects of medicationAltered language processing in autosomal dominant partial epilepsy with auditory featuresThe promise of new antiepileptic drugs.Comparative effects of chronic administrations of gabapentin, pregabalin and baclofen on rat memory using object recognition test.Enhanced working and verbal memory after lamotrigine treatment in pediatric bipolar disorder.Lamotrigine for the treatment of bipolar disorder.Gender and drug effects on neuroimaging in epilepsy.Adverse reactions to new anticonvulsant drugs.Current discoveries on the cognitive effects of antiepileptic drugs.Peripheral nerve injury and gabapentin, but not their combination, impair attentional behavior via direct effects on noradrenergic signaling in the brainReduced anesthetization during the intracarotid amobarbital (Wada) test in patients taking carbonic anhydrase-inhibiting medications.Second generation anticonvulsant medications: their use in children.New antiepileptic drugs: comparative studies of efficacy and cognition.The evolving role of topiramate among other mood stabilizers in the management of bipolar disorder.Negative effects of antiepileptic drugs on mood in patients with epilepsy.Differential cognitive effects of antiepileptic drugs.Infantile spasms and Lennox-Gastaut syndrome.Lamotrigine update and its use in mood disorders.Newer antiepileptic drugs and cognitive issues.Attentional ability in children with epilepsy.Effects of topiramate on cognitive function.Cognitive effects of atypical antipsychotics: focus on bipolar spectrum disorders.Genetic and environmental correlates of topiramate-induced cognitive impairment.Efficacy and safety of levetiracetam in pediatric migraine.Therapy for neurobehavioral disorders in epilepsy.Comprehensive care of the epilepsy patient--control, comorbidity, and cost.Determining the effects of antiepileptic drugs on cognitive function in pediatric patients with epilepsy.Neuropsychology of migraine: present status and future directions.Antiepileptic drugs and the regulation of mood and quality of life (QOL): the evidence from epilepsy.The use of monotherapy in patients with epilepsy: an appraisal of the new antiepileptic drugs.Safety and tolerability of emerging pharmacological treatments for bipolar disorder.Use of the ketogenic diet as a treatment for epilepsy refractory to drug treatment.Topiramate for the treatment of epilepsy and other nervous system disorders.Topiramate and its clinical applications in epilepsy.Topiramate and its effect on fMRI of language in patients with right or left temporal lobe epilepsy.The neuropsychology of recurrent headache.Pharmacokinetics, toxicology and safety of lamotrigine in epilepsy.Epilepsy, Attention-Deficit/Hyperactivity Disorder and Methylphenidate: Critical Examination of Guiding Evidence
P2860
Q27004055-7BB09735-205B-4193-9FAA-64BCA265FAD9Q27005706-D3795F72-B98B-4A9B-A920-0CF338D8F1FCQ28079241-1AA7D1A2-EC5F-4C81-A5DF-63ADD18C5911Q30484710-6C1FB800-916B-4C9C-BF1B-78542930060DQ30674774-84256435-1AB1-4CFB-BCBB-C2E7D2E78435Q33782304-A670EE23-E9AD-4A08-A413-D8DAB6AB0C6AQ33805576-049E7850-0E28-422D-9FEF-5DF024712979Q33838950-BED76DA1-77F1-4481-AC9F-A5F1D7724E9FQ33952937-D4A73269-494C-498C-8064-16825CA8FCDBQ33983920-6DBA2C98-3D36-4661-A07C-EBD6385E43FAQ33999483-609974D3-920E-43C4-BF2A-8EA0383C21D3Q34339287-FDCB529A-29FB-4602-BB19-200CC886D664Q34389266-6D5FBF0A-A6E4-493A-A53B-D3D18ABFA4D7Q34555652-2ADEC5F6-3C25-485D-A141-01269515AC60Q34566302-D0997209-721F-4121-B434-9968D74E1F36Q34576250-B6222F92-668B-4A01-B781-67E099EC6DD0Q34580773-9DC200FD-BBC9-4344-ADD4-7BEE524C1ABDQ34599682-C4FD48D0-AB6A-4621-BE52-7C04BD2CC6C3Q34599704-6624B7E5-C0B4-4CAA-B853-856899379A0AQ34615607-D2E31F53-7761-4967-9C37-94B004DBD19DQ35161333-4D6525FC-49B0-4368-9B62-75414478A012Q35544140-C230D8EC-923F-4638-AE0B-0CDE1AC98491Q35572162-A08A4943-7516-4EC4-87F1-348C0D2687EBQ35618437-45FAA4E6-FF0A-4D02-A955-6ABF3A0274C9Q35658642-55DC55C1-60CE-48C2-AE44-40F0B5F01316Q35687575-8A6EB861-DE14-4A77-9CCE-A2D01E20A57AQ35798249-2704D550-EFD9-40FB-A879-F1858402A408Q35865168-8EAEC18B-4A15-4D03-845B-CEE16441C5B0Q35939585-B0F810CA-C9A5-4085-A8FC-8487B8E81EEAQ36153382-92B2E3AB-8CFC-48F9-ABF3-A27B8DCEC39DQ36169546-BE05131A-1F15-4086-A868-C1FA15496A0DQ36178890-5023BDEB-22BD-4552-886F-A26937775CFAQ36199036-7B0A3BFD-3027-4778-97CE-5AA5F574AC1AQ36307861-072EB228-0FE5-4029-B015-979A989ECD8CQ36390841-E3673FA6-AF79-4692-ADA5-360D26962DD8Q36429751-DF8D2BB0-05C9-46E8-AC11-699D77998E76Q36586668-2995211C-D787-418C-ACB1-7C2EDEB5D770Q36623154-6290641A-9CFA-4C38-A8F1-A8E51F85F02CQ36662898-D8CC5B99-8379-4EE7-9286-27435E0A0F95Q36685077-7F941D04-FF15-4451-B137-89A2186444E0
P2860
Cognitive effects of topiramate, gabapentin, and lamotrigine in healthy young adults.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh-hant
name
Cognitive effects of topiramate, gabapentin, and lamotrigine in healthy young adults.
@en
Cognitive effects of topiramate, gabapentin, and lamotrigine in healthy young adults.
@nl
type
label
Cognitive effects of topiramate, gabapentin, and lamotrigine in healthy young adults.
@en
Cognitive effects of topiramate, gabapentin, and lamotrigine in healthy young adults.
@nl
prefLabel
Cognitive effects of topiramate, gabapentin, and lamotrigine in healthy young adults.
@en
Cognitive effects of topiramate, gabapentin, and lamotrigine in healthy young adults.
@nl
P2093
P356
P1433
P1476
Cognitive effects of topiramate, gabapentin, and lamotrigine in healthy young adults.
@en
P2093
H Hetherington
K Sinclair
R Kuzniecky
P304
P356
10.1212/WNL.52.2.321
P407
P577
1999-01-01T00:00:00Z